The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅳ)
10.3760/cma.j.cn112330-20200525-00008
- VernacularTitle:2020版EAU前列腺癌指南更新解读之四
- Author:
Yonghong LI
1
;
Liru HE
;
Fangjian ZHOU
Author Information
1. 中山大学肿瘤防治中心泌尿外科，广州 510060
- From:
Chinese Journal of Urology
2020;41(6):410-411
- CountryChina
- Language:Chinese
-
Abstract:
Adjuvant therapy is the supplemental treatment to radical prostatectomy (RP) aiming to decrease the risk of relapse, including adjuvant androgen deprivation therapy, adjuvant radiation therapy (ART) and adjuvant chemotherapy. The 2020 version of the EAU guideline updated with a new RCT of ART to emphasize the importance of ART in high-risk patients, and to recommend that RT should be given to the pelvic lymphatics and the prostatic fossa for the pN 1 patients.
